Form 4 for BCPC BALCHEM CORP
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001140361-23-006111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-10 | 2023-02-08 | BCPC | Griffin Jonathan Harrison | SVP, GM, Animal Nutrition | A - Grant | $0.00 | +2,999 | 9,201 | +48% | $0 |
| D | 2023-02-10 | 2023-02-08 | BCPC | Griffin Jonathan Harrison | SVP, GM, Animal Nutrition | F - Tax | $138.09 | -758 | 10.7K | -7% | -$104.7K |
| D | 2023-02-10 | 2023-02-08 | BCPC | Griffin Jonathan Harrison | SVP, GM, Animal Nutrition | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-08 | A | A | 2,279 | $0.00 | 11,480 | D | — | — | (F3) Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2020-2022 performance period. |
| 2 | Common | Common Stock | 2023-02-08 | A | A | 720 | $0.00 | 9,201 | D | — | — | (F1) Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. (F2) Includes acquisition of shares under the Balchem Corporation 401(k) plan. |
| 3 | Common | Common Stock | 2023-02-08 | F | D | 758 | $138.09 | 10,722 | D | — | — | (F4) 758 of the 2,279 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. |
| 4 | Derivative | Stock Option | 2023-02-08 | A | A | 2,500 | $0.00 | 2,500 | D | $138.09 · — to 2033-02-08 | 2,500 Common Stock | (F5) Options vest 20% Year 1; 40% Year 2: and 40% Year 3. |